Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Thalidomide and Epoetin Alfa in Treating Anemia in Patients With Myelodysplastic Syndrome
Phase 2
Completed
- Conditions
- AnemiaLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
- First Posted Date
- 2003-01-28
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Fallon Clinic
- Registration Number
- NCT00053001
- Locations
- 🇺🇸
Fallon Clinic at Worcester Medical Center, Worcester, Massachusetts, United States
🇺🇸UMASS Memorial Cancer Center - University Campus, Worcester, Massachusetts, United States
News
No news found